DURAPHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 29916055
Stationsvej 25, 5771 Stenstrup
emlf@mail.tele.dk
Income statement (kDKK)
2016 | 2017 | 2018 | |
---|---|---|---|
Fiscal period length | 12 | 12 | 12 |
Net sales | |||
Gross profit | - 676.97 | - 428.92 | - 386.63 |
Employee benefit expenses | - 524.27 | - 528.60 | - 127.26 |
Total depreciation | -45.93 | -61.65 | -62.09 |
EBIT | -1 247.17 | -1 019.17 | - 575.98 |
Other financial income | 0.06 | 0.06 | 1.93 |
Other financial expenses | - 388.11 | - 479.13 | - 553.74 |
Pre-tax profit | -1 635.22 | -1 498.23 | -1 127.80 |
Net earnings | -1 635.22 | -1 498.23 | -1 127.80 |
Assets (kDKK)
2016 | 2017 | 2018 | |
---|---|---|---|
Intangible assets total | |||
Machinery and equipment | 249.14 | 209.49 | 16.40 |
Tangible assets total | 249.14 | 209.49 | 16.40 |
Other receivables | 28.50 | 28.50 | 28.50 |
Investments total | 28.50 | 28.50 | 28.50 |
Long term receivables total | |||
Inventories total | |||
Current other receivables | 57.44 | 54.73 | 34.76 |
Short term receivables total | 57.44 | 54.73 | 34.76 |
Cash and bank deposits | 2.64 | 2.61 | 2.88 |
Cash and cash equivalents | 2.64 | 2.61 | 2.88 |
Balance sheet total (assets) | 337.72 | 295.34 | 82.54 |
Equity and liabilities (kDKK)
2016 | 2017 | 2018 | |
---|---|---|---|
Share capital | 125.00 | 125.00 | 125.00 |
Retained earnings | -5 431.55 | -7 066.78 | -8 565.01 |
Profit of the financial year | -1 635.22 | -1 498.23 | -1 127.80 |
Shareholders equity total | -6 941.78 | -8 440.01 | -9 567.81 |
Non-current liabilities total | |||
Current loans from credit institutions | 19.19 | ||
Current owed to group member | 7 250.98 | 8 682.54 | 9 648.60 |
Other non-interest bearing current liabilities | 28.52 | 33.62 | 1.75 |
Current liabilities total | 7 279.50 | 8 735.35 | 9 650.34 |
Balance sheet total (liabilities) | 337.72 | 295.34 | 82.54 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.